4
Changes in Ownership
Hims & Hers Health, Inc. Filed Acc 0001773751-25-000141
Chief Executive Officer sold 91,667 shares at an average $33.57 ($3,077,070)
- Chief Executive Officer acquired 91,667 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dudum Andrew Chief Executive Officer | 2025-04-28 | Option exercise 10b5-1 | +41,667 | $2.43 | $101,251 | 133,770 | D |
| Dudum Andrew Chief Executive Officer | 2025-04-28 | Sale 10b5-1 | −41,667 | $30.19 | $1,257,760 | 92,103 | D |
| Dudum Andrew Chief Executive Officer | 2025-04-29 | Option exercise 10b5-1 | +50,000 | $2.43 | $121,500 | 142,103 | D |
| Dudum Andrew Chief Executive Officer | 2025-04-29 | Sale 10b5-1 | −50,000 | $36.39 | $1,819,310 | 92,103 | D |
| Derivatives | |||||||
| Dudum Andrew Chief Executive Officer | 2025-04-28 | Option exercise · Stock Option (right to buy) 10b5-1 | −41,667 | 1,131,399 | D | ||
| Dudum Andrew Chief Executive Officer | 2025-04-29 | Option exercise · Stock Option (right to buy) 10b5-1 | −50,000 | 1,081,399 | D | ||
| Open-market sales · 91,667 sh · avg $33.57 · $3,077,070 | |||||||
Loading xslF345X05/wk-form4_1746050474.xml…